EDAP TMS S.A. (EDAP)
- Previous Close
7.36 - Open
7.45 - Bid --
- Ask --
- Day's Range
7.07 - 7.66 - 52 Week Range
3.60 - 12.23 - Volume
68,828 - Avg. Volume
38,740 - Market Cap (intraday)
264.55M - Beta (5Y Monthly) 0.64
- PE Ratio (TTM)
-- - EPS (TTM)
-0.61 - Earnings Date May 15, 2024 - May 20, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
12.36
EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments. The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment also offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology; and offers Sonolith i-move, an extracorporeal shockwave lithotripter, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. It markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. The company serves hospitals, urology clinics, and research institutions. EDAP TMS S.A. was incorporated in 1979 and is based in Lyon, France.
www.edap-tms.com307
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: EDAP
Performance Overview: EDAP
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EDAP
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EDAP
Valuation Measures
Market Cap
266.41M
Enterprise Value
229.01M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.14
Price/Book (mrq)
4.41
Enterprise Value/Revenue
3.79
Enterprise Value/EBITDA
-12.45
Financial Highlights
Profitability and Income Statement
Profit Margin
-35.05%
Return on Assets (ttm)
-10.65%
Return on Equity (ttm)
-32.95%
Revenue (ttm)
60.42M
Net Income Avi to Common (ttm)
-21.18M
Diluted EPS (ttm)
-0.61
Balance Sheet and Cash Flow
Total Cash (mrq)
43.47M
Total Debt/Equity (mrq)
14.91%
Levered Free Cash Flow (ttm)
-8.25M